These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 4015706)

  • 21. [Conjugated dinitrocompound dianions as inhibitors of the oxidative deamination of monoamines].
    Gureeva ZP; Mostiaeva LV
    Biokhimiia; 1984 Nov; 49(11):1840-6. PubMed ID: 6549266
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Procaine hydrochloride as a monoamine oxidase inhibitor: implications for Geriatric therapy.
    Fuller RW; Roush BW
    J Am Geriatr Soc; 1977 Feb; 25(2):90-3. PubMed ID: 833415
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aldehyde derivatives of indoleamines and the enhancement of their binding onto brain macromolecules by pentobarbital and acetaldehyde.
    Tabakoff B; Ungar F; Alivisatos SG
    Nat New Biol; 1972 Jul; 238(82):126-8. PubMed ID: 4403003
    [No Abstract]   [Full Text] [Related]  

  • 24. Lesion-induced reductions in trace amine accumulation: dependence on MAO inhibitor pretreatment.
    Nguyen TV; Juorio AV; Greenshaw AJ
    Brain Res Bull; 1989 Feb; 22(2):197-200. PubMed ID: 2495844
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The role of monoamine oxidase in the regulation of mitochondrial energy functions].
    Medvedev AE; Gorkin VZ
    Vopr Med Khim; 1991; 37(5):2-6. PubMed ID: 1759390
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of MAO by substituted tryptamine analogues.
    Balsa D; Fernandez-Alvarez E; Tipton KF; Unzeta M
    J Neural Transm Suppl; 1990; 32():103-5. PubMed ID: 2089079
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The oxidation of tryptamine by the two forms of monoamine oxidase in human tissues.
    Sullivan JP; McDonnell L; Hardiman OM; Farrell MA; Phillips JP; Tipton KF
    Biochem Pharmacol; 1986 Oct; 35(19):3255-60. PubMed ID: 3094536
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of pancreatic islet monoamine oxidase.
    Feldman JM; Chapman B
    Metabolism; 1975 May; 24(5):581-8. PubMed ID: 1092954
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Possible mechanism of selective inhibition of rat liver mitochondrial monoamine oxidase by chlorgiline and deprenyl].
    Severina IS
    Biokhimiia; 1979 Feb; 44(2):195-207. PubMed ID: 435561
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vivo metabolism of serotonin and tryptamine: effect of monoamine oxidase inhibition.
    WEISSBACH H; LOVENBERG W; REDFIELD BG; UDENFRIEND S
    J Pharmacol Exp Ther; 1961 Jan; 131():26-30. PubMed ID: 13784114
    [No Abstract]   [Full Text] [Related]  

  • 31. The effect of pargyline and other monoamine oxidase inhibitors on blood acetaldehyde levels in ethanol-intoxicated mice.
    Dembiec D; MacNamee D; Cohen G
    J Pharmacol Exp Ther; 1976 May; 197(2):332-9. PubMed ID: 944772
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence that a preferred substrate for type B monoamine oxidase mediates stimulus properties of MAO inhibitors: a possible role for beta-phenylethylamine in the cocaine cue.
    Colpaert FC; Niemegeers CJ; Janssen PA
    Pharmacol Biochem Behav; 1980 Oct; 13(4):513-7. PubMed ID: 6107935
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relative activity of some inhibitors of mono-amine oxidase in potentiating the action of tryptamine in vitro and in vivo.
    MAXWELL DR; GRAY WR; TAYLOR EM
    Br J Pharmacol Chemother; 1961 Dec; 17(3):310-20. PubMed ID: 14471627
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The mitochondrial monoamine oxidase-aldehyde dehydrogenase pathway: a potential site of action of daidzin.
    Rooke N; Li DJ; Li J; Keung WM
    J Med Chem; 2000 Nov; 43(22):4169-79. PubMed ID: 11063613
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of three monoamine oxidase inhibitors on ethanol preference in mice.
    Sanders B; Collins AC; Petersen DR; Fish BS
    Pharmacol Biochem Behav; 1977 Mar; 6(3):319-24. PubMed ID: 857255
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Isotope effects in the enzymatic oxidation of tryptamine to 3-indolyl-acetaldehyde.
    Dragulska S; Winnicka E; KaƄska M
    Isotopes Environ Health Stud; 2014 Jun; 50(2):269-76. PubMed ID: 24438014
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Observations on the monamine oxidase activity of rat vasa deferentia, major blood vessels and human saphenous vein.
    Dial EJ; Clarke DE
    Res Commun Chem Pathol Pharmacol; 1977 May; 17(1):145-56. PubMed ID: 877399
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A new type of mitochondrial monoamine oxidase distinct from type-A and type-B.
    Kinemuchi H; Sudo M; Yoshino M; Kawaguchi T; Sunami Y; Kamijo K
    Life Sci; 1983 Jan; 32(5):517-24. PubMed ID: 6823208
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [On the selective inhibition by alpha-substituted tryptamine derivatives of the enzymatic deamination of serotonin].
    Gorkin VZ; Tat'ianenko LV; Suvorov NN; Nekliudov AD
    Biokhimiia; 1967; 32(5):1036-46. PubMed ID: 5599890
    [No Abstract]   [Full Text] [Related]  

  • 40. URINARY TRYPTAMINE AND INDOLE-3-ACETIC ACID EXCRETION BY SCHIZOPHRENIC PATIENTS: USE OF THE TRYPTAMINE/INDOLE ACETIC ACID RATIO AS AN INDEX OF MONOAMINE OXIDASE INHIBITION.
    LABROSSE EH; KOPIN IJ; FELIX WR; WESTLAKE RJ
    J Psychiatr Res; 1964 Oct; 2():185-97. PubMed ID: 14242376
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.